New Trials in Prostate Cancer: Could Your Patient Benefit?
A number of late-phase clinical trials in prostate cancer have opened in recent months. Maybe one of your patients could
Read more
First AI Pathology Program Approved: Helps Detect Prostate Cancer
The US Food and Drug Administration (FDA) has authorized marketing of artificial intelligence (AI) software to help pathologists detect prostate
Read more
Active Surveillance for Prostate Cancer: Switch After 4 Years
Active surveillance instead of immediate aggressive treatment has become a standard of care for men with low-risk prostate cancer, and
Read more
Scientists receive grant to investigate tumor development within a natural environment
Unlike many of us during the COVID-19 pandemic, biological cells are not isolated from the outside world. Chemical variations, intercellular
Read more
New immunotherapy target discovered for malignant brain tumors
Scientists say they have discovered a potential new target for immunotherapy of malignant brain tumors, which so far have resisted
Read more
